(19)
(11) EP 4 188 958 A1

(12)

(43) Date of publication:
07.06.2023 Bulletin 2023/23

(21) Application number: 21766732.8

(22) Date of filing: 29.07.2021
(51) International Patent Classification (IPC): 
C07K 16/28(2006.01)
A61K 39/395(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 16/2839; C07K 2317/24; A61K 2039/505; C07K 2317/94; A61K 39/39591
(86) International application number:
PCT/US2021/043690
(87) International publication number:
WO 2022/026699 (03.02.2022 Gazette 2022/05)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 31.07.2020 US 202063059427 P

(71) Applicants:
  • GENENTECH, INC.
    South San Francisco, CA 94080 (US)
  • F. Hoffmann-La Roche AG
    4070 Basel (CH)

(72) Inventors:
  • PULLEY, Jennifer
    Welwyn Garden City Hertfordshire AL7 1TW (GB)
  • TANG, Meina, Tao
    San Francisco, CA 94080-4990 (US)
  • TOLE, Swati
    San Francisco, CA 94080-4990 (US)
  • TYRRELL, Helen
    Welwyn Garden City Hertfordshire AL7 1TW (GB)
  • ABOUHOSSEIN, Mariam
    San Francisco, CA 94080-4990 (US)
  • AMARCHINTA, Hemanth
    San Francisco, CA 94080-4990 (US)
  • BORUVKA, Audrey
    Mississauga L5N 5M8 (CA)
  • DING, Han, Ting
    San Francisco, CA 94080-4990 (US)
  • FLORES, Heather, L.
    San Francisco, CA 94080-4990 (US)
  • GIESE, Glen, Scott
    San Francisco, CA 94080-4990 (US)
  • RAVANELLO, Renato
    San Francisco, CA 94080-4990 (US)
  • ZHANG, Wenhui
    San Francisco, CA 94080-4990 (US)

(74) Representative: Bernard, Guillaume 
F. Hoffmann-La Roche AG Patent Department Grenzacherstrasse 124
4070 Basel
4070 Basel (CH)

   


(54) ANTI-INTEGRIN BETA7 ANTIBODY FORMULATIONS AND DEVICES